反应详情

A suspension of 1-(2,4-dichlorophenyl)-2-(4-hydroxyphenyl)-3-methyl-5-piperidin-1-yl-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one (153 mg, 0.325 mmol) and DDQ (295 mg, 1.301 mmol) in 1,4-dioxane (12 ml) was stirred at rt for 1 h and 20 min followed by 1 h and 50 min at 35° C. and 2 h and 50 min at 45° C. The solvent was evaporated and the product purified by hplc. The solvent was evaporated and water added. The product was extracted from the water phase with DCM and EtOAc. The combined organic phases were evaporated and the residue was re-suspended in toluene and evaporated to yield the product as a yellow solid (74 mg, 49%). MS m/z 468 (M+H)+.

1. waitfollowed by 1 h and 50 min at 35° C. and 2 h and 50 min at 45° C
2. customThe solvent was evaporated
3. customthe product purified by hplc
4. customThe solvent was evaporated
5. additionwater added
6. extractionThe product was extracted from the water phase with DCM and EtOAc
7. customThe combined organic phases were evaporated
8. customevaporated